InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（12 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
12
T+90 胜率
100%
T+90 平均收益
+16.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Gassert Chad, SVP, Développement Corporatif et Stratégie. Director active across 1 company, notably ANI Pharmaceuticals INC. Cumulatively, 24 reports have been recorded. Breakdown: 1 buy · 12 sells. Total volume traded: €13.9m. Activity tracked since 18 March 2022. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Gassert Chad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
11,116 股@ US$77.154.8% 占其流量Common StockSEC:0001871002-26-000006:0
1,608 股@ US$76.700.9% 占其流量Common StockSEC:0001871002-26-000004:0
1,717 股@ US$77.361.0% 占其流量Common StockSEC:0001871002-26-000004:1
4,269 股@ US$76.251.8% 占其流量Common StockSEC:0001871002-26-000002:0
14,642 股@ US$89.077.9% 占其流量Common StockSEC:0001871002-25-000007:0
20,000 股@ US$86.9711.4% 占其流量Common StockSEC:0001871002-25-000004:0
14,362 股0Common StockSEC:0001871002-25-000002:0
9,574 股0Common StockSEC:0001871002-25-000002:1
20,000 股@ US$63.4410.2% 占其流量Common StockSEC:0001871002-24-000014:0
20,000 股@ US$64.4110.2% 占其流量Common StockSEC:0001871002-24-000012:0
20,000 股@ US$66.6210.7% 占其流量Common StockSEC:0001871002-24-000010:0
20,000 股@ US$67.2510.8% 占其流量Common StockSEC:0001871002-24-000008:0
20,000 股@ US$65.8110.4% 占其流量Common StockSEC:0001871002-24-000006:0
1,635 股@ US$67.670.9% 占其流量Common StockSEC:0001871002-24-000004:0
13,421 股0Common StockSEC:0001871002-24-000002:0
20,000 股@ US$56.489.3% 占其流量Common StockSEC:0001871002-23-000009:0
20,000 股@ US$64.7010.3% 占其流量Common StockSEC:0001871002-23-000006:0
20,000 股@ US$51.068.0% 占其流量Common StockSEC:0001871002-23-000004:0
20,000 股@ US$53.438.4% 占其流量Common StockSEC:0001104659-23-078742:0
20,000 股@ US$51.328.1% 占其流量Common StockSEC:0001104659-23-074398:0
17,369 股0Common StockSEC:0001104659-23-041729:0
11,578 股0Common StockSEC:0001104659-23-041729:1
5,000 股@ US$27.14880.8% 占其流量Common StockSEC:0001415889-22-003267:0
标准退出：2022年6月16日 (T+90)
383,226 股Common StockSEC:0001415889-21-005442:0
24 条申报中的 24 条
About Gassert Chad
Gassert Chad is SVP, Corporate Development and Strategy at ANI Pharmaceuticals INC (XNAS). He has 24 filings in total, and among the recent filings available between 2021-11-23 and 2026-03-02, the reported amounts are 122297 in buys and 13793803 in sells, with the modal transaction nature indicated as Sale.
